Clinical trial

Amiloride Clinical Trial In Optic Neuritis

NCT01802489

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-02-01

PhasePHASE2

Study timeline

Study start (unknown)2013-02-01Date precision: month

Registry last updated2018-05-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Optic Neuritisverified · MONDO: optic neuritis

Multiple Sclerosisverified · MONDO: multiple sclerosis

Interventions

AmilorideDRUG · verified · RxNorm: amiloride

PlaceboDRUG

Sponsors & collaborators

University of Oxfordlead sponsor

Multiple Sclerosis Society of Great Britain and Northern Irelandcollaborator

Mapped research locations

OxfordUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01802489 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.